Policy & Regulation

Special report

REGenableMED Special Report

30-08-17

Policy & Regulation

• EuroStemCell resource

EuroGCT: Information on Gene and Cell Therapy

Blood Stem Cells CAR-T Therapy

DNA teaser

What are 'unproven' therapies?

Clinical Trials Current and Potential Uses

Human blastocyst at 6 days old

Creating 'embryos' in a dish: what does it mean for the future of science?

18-03-21

Ethics and Society Organoids

In the Spotlight: The First Gene-Edited Babies

04-03-20

Ethics and Society Policy & Regulation

The Northern Alliance Advanced Therapy Treatment Centre and ‘Institutional Readiness’

14-03-19

Policy & Regulation Research

unproven in australia

Australia: Finally, unproven stem cell clinic practices might be curtailed

28-10-17

Ethics and Society Policy & Regulation

ISSCR Responds to FDA Announcement of Enforcement Direction

29-08-17

Policy & Regulation Stem Cell News

synopsis icon

REGenableMED Project Synopsis

Ethics and Society Policy & Regulation

Clinicians being interviewed

Stem Cell Tourism: Experts call for tighter regulation

05-07-17

Clinical Trials Ethics and Society

EU Flag

Regulation of stem cell research in Europe

Policy & Regulation

UK Flag

Regulation of stem cell research in the United Kingdom

18-07-17

Policy & Regulation

Ethics to Hype: How Media Frames Regenerative Medicine

Ethics to Hype: How Media Frames Regenerative Medicine

06-02-17

Ethics and Society Policy & Regulation

Policy Briefings: Regenerative medicine, industry and clinical translation

Clinical Trials Policy & Regulation

ISSCR guidelines

ISSCR releases new global guidelines for stem cell research

Clinical Trials Policy & Regulation

'Embryonic Stem Cell Patents Banned': Theory of Knowledge

'Embryonic Stem Cell Patents Banned': Theory of Knowledge

11-04-12

Embryonic Stem Cells Ethics and Society

GMP facility

Regenerative medicine and regulation: what’s GMP got to do with it?

Industry Policy & Regulation